
Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F:
Interleukin-6 deficient mice are protected from bone loss caused by
estrogen depletion.
EMBO Journal 1994 Mar 1;13(5):1189-96
ABSTRACT
Interleukin-6 (IL-6) is a multifunctional cytokine whose circulating
levels are under physiological conditions below detection, but whose
production is rapidly and strongly induced by several pathological
and inflammatory stimuli. IL-6 has been implicated in a number of
cell functions connected to immunity and hematopoiesis. Recently, it
has been proposed to act as a stimulator of osteoclast formation and
activity, in particular following estrogen depletion. The purpose of
this study was to gain additional insights into the role of IL-6
during development, as well as in physiological and pathological
conditions. We report here that IL-6 deficient mice generated by
gene targeting are viable and do not present any evident phenotypic
abnormality. However, analysis of bone metabolism revealed a
specific bone phenotype. IL-6 deficient female mice have a normal
amount of trabecular bone, but higher rates of bone turnover than
control littermates. Estrogen deficiency induced by ovariectomy
causes in wild type animals a significant loss of bone mass together
with an increase in bone turnover rates. Strikingly, ovariectomy
does not induce any change in either bone mass or bone remodeling
rates in the IL-6 deficient mice. These findings indicate that IL-6
plays an important role in the local regulation of bone turnover
and, at least in mice, appears to be essential for the bone loss
caused by estrogen deficiency.